Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Comparative Bioavailability Study of a New GFT505 Formulation With the Existing One After 120 mg Single Oral GFT505 Administration and Assessment of the Gender Effect in Young Healthy Male and Female Volunteers Followed by a Single and Multiple Ascending Dose Safety, Tolerability and Pharmacokinetic Study of GFT505 in Overweight or Obese Subjects and in Diabetic Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01474161
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:24.963961+00:00
Published At
2012-11-27T00:00:00+00:00
Record Updated At
2012-11-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Type 2 Diabetes", "Diabetes Mellitus, Type 2", "Metabolic Diseases", "Cardiovascular Diseases", "Obese", "Dyslipidemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2012-11-27"
protocolSection.identificationModule.nctId
"NCT01474161"
protocolSection.identificationModule.officialTitle
"Comparative Bioavailability Study of a New GFT505 Formulation With the Existing One After 120 mg Single Oral GFT505 Administration and Assessment of the Gender Effect in Young Healthy Male and Female Volunteers Followed by a Single and Multiple Ascending Dose Safety, Tolerability and Pharmacokinetic Study of GFT505 in Overweight or Obese Subjects and in Diabetic Patients"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Type 2 Diabetes (protocolSection.conditionsModule.conditions)
  • Diabetes Mellitus, Type 2 (protocolSection.conditionsModule.conditions)
  • Metabolic Diseases (protocolSection.conditionsModule.conditions)
  • Cardiovascular Diseases (protocolSection.conditionsModule.conditions)
  • Obese (protocolSection.conditionsModule.conditions)
  • Dyslipidemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.